X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-10-21 | ANGO | Angiodynamics Inc | Weiss Lawrence T | SVP, GC | P - Purchase | $11.81 | +10,000 | 93,597 | +12% | +$118,100 | ||||||
2025-10-21 | TOFB | Tofutti Brands Inc | A-6684 Ltd. | 10% | P - Purchase | $0.70 | +152 | 616,038 | 0% | +$106 | ||||||
2025-10-21 | MGTX | Meiragtx Holdings Plc | Giroux Richard | CFO, COO | S - Sale | $8.87 | -24,000 | 919,646 | -3% | -$212,880 | ||||||
| M | 2025-10-17 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Global Value Investment Corp. | 10% | P - Purchase | $1.59 | +75,423 | 3,877,126 | +2% | +$119,965 | |||||
| M | 2025-10-17 | RMCF | Rocky Mountain Chocolate Factory, Inc. | Geygan Jeffrey Richart | Interim CEO, 10% | P - Purchase | $1.59 | +75,423 | 1,939,977 | +4% | +$119,965 | |||||
| M | 2025-10-20 | JBL | Jabil Inc | Crowley Matthew | EVP, Global Business Units | S - Sale | $205.73 | -6,533 | 58,736 | -10% | -$1,344,043 | |||||
| D | 2025-10-17 | ANET | Arista Networks, Inc. | Duda Kenneth | Pres, CTO | S - Sale+OE | $142.75 | -56,000 | 3,273,917 | -2% | -$7,993,813 | |||||
| M | 2025-10-14 | CGEM | Cullinan Therapeutics, Inc. | Lynx1 Capital Management LP | 10% | P - Purchase | $8.46 | +248,749 | 17,361,949 | +1% | +$2,103,912 | |||||
2025-10-21 | IPGP | Ipg Photonics Corp | Scherbakov Eugene A | Dir, 10% | S - Sale | $87.64 | -2,700 | 67,430 | -4% | -$236,633 | ||||||
| D | 2025-10-21 | CYTK | Cytokinetics Inc | Malik Fady Ibraham | EVP Research, Development | S - Sale+OE | $58.22 | -2,105 | 140,610 | -1% | -$122,553 | |||||
2025-10-17 | ELVN | Enliven Therapeutics, Inc. | Kintz Samuel | Pres, CEO | S - Sale | $21.33 | -12,500 | 902,892 | -1% | -$266,654 | ||||||
| M | 2025-10-17 | IPGP | Ipg Photonics Corp | Ip Fibre Devices Ltd | 10% | S - Sale | $87.00 | -64,167 | 6,785,670 | -1% | -$5,582,496 | |||||
2025-10-20 | IPGP | Ipg Photonics Corp | Ness Trevor | SVP, Sales, Strategic Bus Dev | S - Sale | $87.00 | -1,678 | 38,887 | -4% | -$145,978 | ||||||
| D | 2025-10-20 | MU | Micron Technology Inc | Allen Scott R. | CVP, Chief Accounting Officer | S - Sale+OE | $210.02 | -8,800 | 40,237 | -18% | -$1,848,176 | |||||
| M | 2025-10-17 | VOR | Vor Biopharma Inc. | Reprogrammed Interchange LLC | 10% | S - Sale | $30.19 | -37,533 | 1,166,909 | -3% | -$1,133,103 | |||||
2025-10-20 | MBX | Mbx Biosciences, Inc. | Hawryluk P. Kent | Pres, CEO | P - Purchase | $13.64 | +20,000 | 949,674 | +2% | +$272,790 | ||||||
| DM | 2025-10-17 | PAHC | Phibro Animal Health Corp | Bendheim Jack | Pres, CEO, 10% | S - Sale+OE | $40.37 | -16,775 | 90,739 | -16% | -$677,198 | |||||
2025-10-21 | SION | Sionna Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $34.22 | -88,878 | 2,995,602 | -3% | -$3,041,683 | ||||||
| D | 2025-10-20 | TDG | Transdigm Group Inc | Reiss Joel | Co-COO | S - Sale+OE | $1,279.59 | -3,000 | 3,600 | -45% | -$3,838,757 | |||||
| M | 2025-10-17 | ALMU | Aeluma, Inc. | Tompkins Mark N. | 10% | S - Sale | $16.67 | -77,500 | 2,319,988 | -3% | -$1,291,919 | |||||
| D | 2025-10-17 | DNA | Ginkgo Bioworks Holdings, Inc. | Coen Steven P. | See remarks | S - Sale+OE | $13.65 | -1,312 | 6,738 | -16% | -$17,907 | |||||
| D | 2025-10-20 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | Altmeyer Anne | Dir | S - Sale+OE | $20.50 | -1,060 | 6,191 | -15% | -$21,730 | |||||
| D | 2025-10-20 | UTHR | United Therapeutics Corp | Benkowitz Michael | Pres, COO | S - Sale+OE | $427.41 | -22,500 | 2,648 | -89% | -$9,616,703 | |||||
2025-10-20 | HSY | Hershey Co | Voskuil Steven E | SVP, CFO | S - Sale | $187.52 | -1,500 | 56,819 | -3% | -$281,280 | ||||||
| D | 2025-10-20 | SLDB | Solid Biosciences Inc. | Brooks Gabriel | Chief Medical Officer | S - Sale+OE | $5.96 | -2,895 | 33,819 | -8% | -$17,254 | |||||
2025-10-20 | CMC | Commercial Metals Co | McPherson John R | Dir | P - Purchase | $58.09 | +1,722 | 23,232 | +8% | +$100,037 | ||||||
| D | 2025-10-20 | SER | Serina Therapeutics, Inc. | Moreadith Randall | Chief Scientific Officer | S - Sale+OE | $4.97 | -6,500 | 0 | -100% | -$32,287 | |||||
2025-10-20 | SINT | Sintx Technologies, Inc. | Olson Eric K. | Pres, CEO | P - Purchase | $3.40 | +5,800 | 30,775 | +23% | +$19,720 | ||||||
| M | 2025-10-16 | SION | Sionna Therapeutics, Inc. | Booth Bruce | Dir | S - Sale | $32.30 | -286,369 | 3,084,480 | -8% | -$9,251,102 | |||||
| M | 2025-10-16 | NVDA | Nvidia Corp | Huang Jen Hsun | Pres, CEO | S - Sale | $182.48 | -225,000 | 852,358,603 | 0% | -$41,058,402 | |||||
| M | 2025-10-16 | SCWO | 374Water Inc. | Nagar Yaacov | 10% | S - Sale | $0.46 | -217,099 | 32,977,358 | -1% | -$99,486 | |||||
| M | 2025-10-16 | BYSI | Beyondspring Inc. | Decheng Capital China Life Sciences Usd Fund Iii, L.P. | 10% | S - Sale | $1.73 | -131,311 | 4,028,036 | -3% | -$227,675 | |||||
| D | 2025-10-16 | FDMT | 4D Molecular Therapeutics, Inc. | Bizily Scott | GC | S - Sale+OE | $10.17 | -1,635 | 5,188 | -24% | -$16,628 | |||||
| D | 2025-10-17 | JNJ | Johnson & Johnson | Reed John C | EVP, Innovative Medicine, R, D | S - Sale+OE | $192.71 | -21,721 | 10,658 | -67% | -$4,185,793 | |||||
2025-10-20 | QCOM | Qualcomm Inc/De | Palkhiwala Akash J. | CFO, COO | S - Sale | $166.06 | -8,335 | 36,541 | -19% | -$1,384,142 | ||||||
| M | 2025-10-16 | LVTX | Lava Therapeutics Nv | Cooperatieve Gilde Healthcare IV U.A. | 10% | S - Sale | $1.47 | -2,871,370 | 1,947,781 | -60% | -$4,224,719 | |||||
| M | 2025-10-15 | BGMS | Bio Green Med Solution, Inc. | Kua Khai Loon | 10% | S - Sale | $4.33 | -95,683 | 242,477 | -28% | -$414,295 | |||||
2025-10-16 | BGMS | Bio Green Med Solution, Inc. | Fitters Diversified Berhad | 10% | S - Sale | $5.50 | -26,051 | 479,707 | -5% | -$143,281 | ||||||
| D | 2025-10-17 | CRSP | Crispr Therapeutics AG | Kulkarni Samarth | CEO | S - Sale+OE | $67.91 | -50,895 | 339,863 | -13% | -$3,456,279 | |||||
2025-10-17 | JBL | Jabil Inc | Mondello Mark T | Exec COB | S - Sale | $207.77 | -40,000 | 1,258,942 | -3% | -$8,310,963 | ||||||
2025-10-16 | MTSI | Macom Technology Solutions Holdings, Inc. | Dennehy Robert | SVP, Operations | S - Sale | $140.02 | -4,128 | 6,552 | -39% | -$578,003 | ||||||
2025-10-16 | BLFS | Biolife Solutions Inc | Goswami Joydeep | Dir | S - Sale | $0.00 | -1,334 | 46,652 | -3% | -$0 | ||||||
2025-10-17 | MBX | Mbx Biosciences, Inc. | Hoerter Steven L. | Dir | P - Purchase | $13.25 | +20,000 | 20,000 | New | +$264,984 | ||||||
| DM | 2025-10-17 | UTHR | United Therapeutics Corp | Rothblatt Martine A | CHAIRPERSON, CEO | S - Sale+OE | $427.63 | -8,000 | 644,489 | -1% | -$3,421,037 | |||||
| D | 2025-10-16 | RYTM | Rhythm Pharmaceuticals, Inc. | Shulman Joseph | Chief Technical Officer | S - Sale+OE | $112.03 | -14,437 | 8,509 | -63% | -$1,617,337 | |||||
2025-10-17 | OUST | Ouster, Inc. | Chung Megan | GC, Secretary | S - Sale | $31.02 | -5,837 | 197,199 | -3% | -$181,058 | ||||||
2025-10-17 | GOVX | Geovax Labs, Inc. | Spencer John N Jr | Dir | P - Purchase | $0.55 | +10,000 | 21,402 | +88% | +$5,498 | ||||||
2025-10-16 | NDSN | Nordson Corp | Kelley Joseph P | EVP | S - Sale | $232.39 | -2,300 | 8,605 | -21% | -$534,497 | ||||||
| D | 2025-10-16 | UTHR | United Therapeutics Corp | Mahon Paul A | EVP, GC | S - Sale+OE | $431.50 | -11,000 | 36,781 | -23% | -$4,746,494 | |||||
| M | 2025-10-15 | ALMU | Aeluma, Inc. | Tompkins Mark N. | 10% | S - Sale | $20.09 | -65,000 | 2,397,488 | -3% | -$1,305,675 | |||||
| DM | 2025-10-15 | ROIV | Roivant Sciences Ltd. | Venker Eric | Pres, Immunovant CEO | S - Sale+OE | $16.99 | -851,383 | 1,504,959 | -36% | -$14,467,502 | |||||
2025-10-17 | ARTV | Artiva Biotherapeutics, Inc. | Aslan Fred | Pres, CEO | S - Sale | $6.00 | -25,500 | 356,721 | -7% | -$153,000 | ||||||
2025-10-15 | BLFS | Biolife Solutions Inc | Casdin Partners Master Fund, L.P. | 10% | S - Sale | $28.55 | -750,000 | 5,957,165 | -11% | -$21,410,325 | ||||||
2025-10-15 | SARO | Standardaero, Inc. | Trapp Alex | Chief Strategy Officer | S - Sale | $29.21 | -10,000 | 0 | -100% | -$292,100 | ||||||
2025-10-17 | LXEO | Lexeo Therapeutics, Inc. | See Tai Sandi | Chief Development Officer | S - Sale | $8.94 | -3,888 | 65,862 | -6% | -$34,767 | ||||||
2025-10-17 | LXEO | Lexeo Therapeutics, Inc. | Robertson Jenny | GC | S - Sale | $8.94 | -3,526 | 68,930 | -5% | -$31,530 | ||||||
2025-10-17 | LXEO | Lexeo Therapeutics, Inc. | Otero Jose Manuel | Chief Technical Officer | S - Sale | $8.94 | -2,115 | 64,197 | -3% | -$18,913 | ||||||
2025-10-17 | LXEO | Lexeo Therapeutics, Inc. | Adler Eric | Chief Medical Officer | S - Sale | $8.94 | -3,382 | 73,261 | -4% | -$30,242 | ||||||
2025-10-17 | LXEO | Lexeo Therapeutics, Inc. | Townsend Richard Nolan | CEO | S - Sale | $8.94 | -13,133 | 242,118 | -5% | -$117,436 | ||||||
2025-10-16 | CELH | Celsius Holdings, Inc. | Langhans Jarrod | CFO | S - Sale | $65.00 | -5,000 | 99,227 | -5% | -$325,000 | ||||||
2025-10-16 | QSI | Quantum-Si Inc | Rothberg Jonathan M | Dir, 10% | S - Sale | $3.07 | -26,095 | 33,644,178 | 0% | -$80,112 | ||||||
2025-10-15 | KTOS | Kratos Defense & Security Solutions, Inc. | Mendoza Marie | SVP, GC | S - Sale | $97.10 | -1,440 | 60,396 | -2% | -$139,824 | ||||||
2025-10-15 | KTOS | Kratos Defense & Security Solutions, Inc. | Carrai Phillip D | Pres, STC Division | S - Sale | $96.90 | -6,000 | 298,685 | -2% | -$581,389 | ||||||
| M | 2025-10-15 | VOR | Vor Biopharma Inc. | Reprogrammed Interchange LLC | 10% | S - Sale | $31.88 | -73,676 | 1,204,442 | -6% | -$2,348,744 | |||||
| D | 2025-10-16 | AAPL | Apple Inc. | Parekh Kevan | SVP, CFO | S - Sale+OE | $247.39 | -4,199 | 8,765 | -32% | -$1,038,787 | |||||
2025-10-15 | RUN | Sunrun Inc. | Steele Jeanna | Chief Legal, People Officer | S - Sale | $21.71 | -4,475 | 361,789 | -1% | -$97,148 | ||||||
| M | 2025-10-15 | VOR | Vor Biopharma Inc. | Ra Capital Management, L.P. | Dir, 10% | S - Sale | $29.54 | -464,025 | 15,104 | -97% | -$13,707,361 | |||||
2025-10-15 | KROS | Keros Therapeutics, Inc. | Pontifax Management 4 G.P. (2015) Ltd. | 10% | S - Sale | $17.75 | -4,787,331 | 10,500 | -100% | -$84,975,125 | ||||||
| D | 2025-10-15 | INDI | Indie Semiconductor, Inc. | McClymont Donald | CEO | S - Sale+OE | $6.01 | -200,000 | 5,170,142 | -4% | -$1,201,320 | |||||
| D | 2025-10-15 | AMD | Advanced Micro Devices Inc | Papermaster Mark D | CTO, EVP | S - Sale+OE | $224.28 | -16,800 | 1,714,505 | -1% | -$3,767,863 | |||||
| DM | 2025-10-15 | SION | Sionna Therapeutics, Inc. | Cloonan Michael | Pres, CEO | S - Sale+OE | $31.28 | -25,200 | 547,343 | -4% | -$788,153 | |||||
2025-10-17 | VIRC | Virco Mfg Corporation | Virtue Douglas A | EVP | P - Purchase | $7.34 | +13,022 | 861,839 | +2% | +$95,581 | ||||||
| M | 2025-10-15 | CRCT | Cricut, Inc. | Ashish Arora | CEO, 10% | S - Sale | $5.35 | -49,665 | 2,668,146 | -2% | -$265,862 | |||||
2025-10-16 | SYM | Symbotic Inc. | Ladensohn David A | 10% | S - Sale | $74.44 | -13,500 | 6,500 | -68% | -$1,004,974 | ||||||
2025-10-15 | SYM | Symbotic Inc. | Boyd William M III | Chief Strategy Officer | S - Sale | $75.08 | -2,660 | 26,769 | -9% | -$199,720 | ||||||
| D | 2025-10-15 | EVLV | Evolv Technologies Holdings, Inc. | Ellenbogen Michael | Dir | S - Sale+OE | $8.26 | -80,745 | 2,235,096 | -3% | -$666,954 | |||||
| M | 2025-10-15 | IRON | Disc Medicine, Inc. | Bitterman Kevin | Dir | S - Sale | $85.97 | -93,585 | 436,549 | -18% | -$8,045,252 | |||||
| D | 2025-10-16 | ERII | Energy Recovery, Inc. | Yeung William | GC | S - Sale+OE | $16.50 | -3,530 | 102,937 | -3% | -$58,245 | |||||
2025-10-15 | AMKR | Amkor Technology, Inc. | Rutten Guillaume Marie Jean | Pres, CEO | S - Sale | $30.74 | -10,000 | 356,699 | -3% | -$307,400 | ||||||
| M | 2025-10-10 | MLSS | Milestone Scientific Inc. | Bp4 S.R.L. | 10% | S - Sale | $0.54 | -50,158 | 9,155,226 | -1% | -$27,273 | |||||
| D | 2025-10-15 | SERV | Serve Robotics Inc. /De/ | Abraham Euan | Chief Hardware, Mftg Offcr | S - Sale+OE | $17.99 | -25,000 | 250,539 | -9% | -$449,750 | |||||
| D | 2025-10-16 | NUVL | Nuvalent, Inc. | Porter James Richard | Pres, CEO | S - Sale+OE | $90.63 | -27,000 | 249,062 | -10% | -$2,447,021 | |||||
| DM | 2025-10-15 | NUVL | Nuvalent, Inc. | Miller Deborah Ann | GC | S - Sale+OE | $90.72 | -28,000 | 49,086 | -36% | -$2,540,290 | |||||
| D | 2025-10-15 | NUVL | Nuvalent, Inc. | Pelish Henry E. | Chief Scientific Officer | S - Sale+OE | $90.04 | -14,205 | 65,963 | -18% | -$1,279,018 | |||||
| D | 2025-10-15 | NUVL | Nuvalent, Inc. | Balcom Alexandra | CFO | S - Sale+OE | $85.57 | -1,683 | 61,734 | -3% | -$144,014 | |||||
2025-10-16 | SDGR | Schrodinger, Inc. | Dugan Margaret | Chief Medical Officer | S - Sale | $21.07 | -1,395 | 24,574 | -5% | -$29,387 | ||||||
| D | 2025-10-15 | RNA | Avidity Biosciences, Inc. | McCarthy Teresa | CHRO | S - Sale+OE | $50.15 | -20,000 | 97,130 | -17% | -$1,003,058 | |||||
| D | 2025-10-15 | DELL | Dell Technologies Inc. | Kullman Ellen Jamison | Dir | S - Sale+OE | $153.56 | -79,806 | 65,662 | -55% | -$12,255,009 | |||||
| M | 2025-10-15 | VIR | Vir Biotechnology, Inc. | Svf Endurance (Cayman) Ltd | 10% | S - Sale | $6.08 | -29,515 | 15,340,494 | 0% | -$179,563 | |||||
2025-10-16 | APLS | Apellis Pharmaceuticals, Inc. | Watson David O. | GC | S - Sale | $25.22 | -5,000 | 173,866 | -3% | -$126,100 | ||||||
2025-10-16 | PRAX | Praxis Precision Medicines, Inc. | Adage Capital Management, L.P. | 10% | S - Sale | $105.76 | -313,910 | 4,421,660 | -7% | -$33,198,124 | ||||||
| A | 2025-09-12 | BKSY | Blacksky Technology Inc. | Ward Tracy | SVP, Controller | S - Sale | $17.45 | -681 | 44,426 | -2% | -$11,883 | |||||
| A | 2025-09-12 | BKSY | Blacksky Technology Inc. | Lin Christiana L | GC, CAO | S - Sale | $17.45 | -22,742 | 403,946 | -5% | -$396,848 | |||||
| A | 2025-09-12 | BKSY | Blacksky Technology Inc. | Dubois Henry Edward | CFO | S - Sale | $17.45 | -29,943 | 476,285 | -6% | -$522,505 | |||||
| A | 2025-09-12 | BKSY | Blacksky Technology Inc. | O'Toole Brian E | CEO, Pres | S - Sale | $17.45 | -31,519 | 1,001,937 | -3% | -$550,007 | |||||
2025-10-15 | CIEN | Ciena Corp | Rothenstein David M | SVP, Chief Strategy Officer | S - Sale | $170.22 | -2,500 | 185,690 | -1% | -$425,543 | ||||||
2025-10-15 | AEIS | Advanced Energy Industries Inc | Delsanto Anne | Dir | S - Sale | $186.99 | -240 | 7,614 | -3% | -$44,878 | ||||||
| D | 2025-10-15 | AQST | Aquestive Therapeutics, Inc. | Jung Cassie | COO | S - Sale+OE | $7.01 | -67,575 | 242,771 | -22% | -$473,701 | |||||
2025-10-15 | AQST | Aquestive Therapeutics, Inc. | Kraus Carl N | Chief Medical Officer | S - Sale | $7.00 | -20,272 | 282,475 | -7% | -$141,904 | ||||||
2025-10-15 | AQST | Aquestive Therapeutics, Inc. | Boyd Peter E. | See Remarks | S - Sale | $7.00 | -10,000 | 268,323 | -4% | -$70,000 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |